Cargando…

Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?

INTRODUCTION: Medullary thyroid cancer (MTC) is a rare thyroid tumour whose management in advanced stages is challenging, despite effective therapeutic options having expanded in recent years. Proteasome inhibitors (PrIn) have shown the ability to improve patient outcomes, including survival and qua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fanciulli, Giuseppe, Modica, Roberta, La Salvia, Anna, Grossrubatscher, Erika Maria, Florio, Tullio, Ferraù, Francesco, Veresani, Alessandro, Russo, Flaminia, Colao, Annamaria, Faggiano, Antongiulio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157225/ https://www.ncbi.nlm.nih.gov/pubmed/37152939 http://dx.doi.org/10.3389/fendo.2023.1145926

Ejemplares similares

Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
por: Di Molfetta, Sergio, et al.
Publicado: (2021)

Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy
por: Grossrubatscher, Erika, et al.
Publicado: (2020)

Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches
por: Lania, Andrea, et al.
Publicado: (2021)

Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers
por: Giannetta, Elisa, et al.
Publicado: (2021)

Commentary: Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management
por: Fanciulli, Giuseppe, et al.
Publicado: (2021)

Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
por: Fanciulli, Giuseppe, et al.
Publicado: (2022)

Editorial—Special Issue: Foreword to the Special Issue on NIKE: Neuroendocrine Tumors, Innovation in Knowledge and Education
por: Faggiano, Antongiulio, et al.
Publicado: (2021)

What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature
por: Giannetta, Elisa, et al.
Publicado: (2022)

Immune Checkpoint Blockade in Lung Carcinoids with Aggressive Behaviour: One More Arrow in Our Quiver?
por: Di Molfetta, Sergio, et al.
Publicado: (2022)

Diabetes and Cancer
por: Colao, Annamaria, et al.
Publicado: (2011)

Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors
por: Barrea, Luigi, et al.
Publicado: (2021)

Vitamin D and Cancer
por: Vuolo, Laura, et al.
Publicado: (2012)

Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
por: Giannetta, Elisa, et al.
Publicado: (2021)

Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
por: Modica, Roberta, et al.
Publicado: (2022)

Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks
por: Fanciulli, Giuseppe, et al.
Publicado: (2020)

Genetic-Clinical Profile of Subjects with Apparently Sporadic Extra-Adrenal Paragangliomas
por: Ramundo, Valeria, et al.
Publicado: (2012)

Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
por: Vitale, Giovanni, et al.
Publicado: (2021)

Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask
por: Albertelli, Manuela, et al.
Publicado: (2021)

Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues
por: Gallo, Marco, et al.
Publicado: (2021)

Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead
por: Colao, Annamaria, et al.
Publicado: (2020)

Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC)
por: Modica, Roberta, et al.
Publicado: (2023)

Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?
por: Barrea, Luigi, et al.
Publicado: (2021)

Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1
por: Modica, Roberta, et al.
Publicado: (2023)

IGF-I Influences Everolimus Activity in Medullary Thyroid Carcinoma
por: Gentilin, Erica, et al.
Publicado: (2015)

Partitioning of Bronchopulmonary Carcinoids in Two Different Prognostic Categories by Ki-67 Score
por: Grimaldi, Franco, et al.
Publicado: (2011)

Update on Targeted Therapy in Medullary Thyroid Cancer
por: Okafor, Christian, et al.
Publicado: (2021)

Thirty synchronous medullary and papillary thyroid carcinomas
por: Zhang, Daqi, et al.
Publicado: (2023)

Editorial: Neuroendocrine tumors: the road to precision medicine
por: La Salvia, Anna, et al.
Publicado: (2023)

Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
por: Yue, Wenliang, et al.
Publicado: (2022)

Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature
por: Feola, Tiziana, et al.
Publicado: (2020)

Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors
por: Altieri, Barbara, et al.
Publicado: (2020)

Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
por: Matrone, Antonio, et al.
Publicado: (2022)

The Prediction of Metastases of Lateral Cervical Lymph Node in Medullary Thyroid Carcinoma
por: Zhou, Tian-Han, et al.
Publicado: (2021)

Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines
por: Zhang, Daqi, et al.
Publicado: (2022)

A Benign Medullary Thyroid Cancer
por: Pishdad, Reza, et al.
Publicado: (2022)

Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma
por: Censi, Simona, et al.
Publicado: (2021)

Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows
por: Censi, Simona, et al.
Publicado: (2021)

Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients
por: Capezzone, Marco, et al.
Publicado: (2022)

Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies
por: Capodanno, Ylenia, et al.
Publicado: (2021)

Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
por: Park, Hyunju, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hbelpu3av4t23tglfke4n63mjl